US Patent

US8101593 — Formulations of deoxycholic acid and salts thereof

Formulation · Assigned to Kythera Biopharmaceuticals LLC · Expires 2030-03-02 · 4y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects aqueous pharmaceutical formulations of sodium deoxycholate, specifically those with less than 5% concentration and a pH between 8.0 and 8.5.

USPTO Abstract

The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Drugs covered by this patent

Patent Metadata

Patent number
US8101593
Jurisdiction
US
Classification
Formulation
Expires
2030-03-02
Drug substance claim
No
Drug product claim
Yes
Assignee
Kythera Biopharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.